TVRD

Tvardi Therapeutics, Inc. Common Stock
TVRD

Overview Fund Activity

49 hedge funds and large institutions have $149M invested in Tvardi Therapeutics, Inc. Common Stock in 2014 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 17 increasing their positions, 11 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
49
Holders Change
+7
Holders Change %
+16.67%
% of All Funds
1.41%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
15
Increased
17
Reduced
11
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
AAM
Aberdeen Asset Management
United Kingdom
+$15.1M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$2.48M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$2.37M
4
TA
Teachers Advisors
New York
+$1.8M
5
State Street
State Street
Massachusetts
+$1.05M

Top Sellers

1
LBG
Lloyds Banking Group
United Kingdom
-$16.6M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$2.47M
3
EMFAT
Emerald Mutual Fund Advisers Trust
Pennsylvania
-$1.9M
4
EA
Emerald Advisers
Pennsylvania
-$1.74M
5
Jennison Associates
Jennison Associates
New York
-$1.17M
Name Holding Trade Value Shares
Change 		Shares
Change %
EMFAT
51
Emerald Mutual Fund Advisers Trust
Pennsylvania
– -$1.9M -2,841 Closed
EA
52
Emerald Advisers
Pennsylvania
– -$1.74M -2,592 Closed
CBOA
53
Commonwealth Bank of Australia
Australia
– -$521K -778 Closed
EEG
54
E.E. Geduld
– -$242K -361 Closed
Jane Street
55
Jane Street
New York
– -$230K -343 Closed
SCA
56
SAC Capital Advisors
Connecticut
– -$208K -310 Closed
TRCT
57
Tower Research Capital (TRC)
New York
– -$68K -102 Closed
1 2
3